Source: Milan 2017 - Educational material



Rating:

Share or cite this content

Citations should be made in the following way:
PG1 Re-defining the role of chest physicians in lung cancer:ÿnew opportunities in diagnostics and therapy. Milan 2017 - Educational material

Member's Comments

No comment yet.

Related content which might interest you: The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 The clinical benefit of personalised medicine in lung cancer Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms Year: 2014 The lung cancer patient, the pneumologist and palliative care: a developing alliance Source: Eur Respir J 2015; 45: 211-226 Year: 2015 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 The role of a trained respiratory physician in lung cancer management Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic Source: Eur Respir J, 56 (2) 2001621; 10.1183/13993003.01621-2020 Year: 2020 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Practical tools for implementing early palliative care in advanced lung cancer Source: Eur Respir J 2016; 47: 1010-1012 Year: 2016 Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 COVID-19 and the management of thoracic cancer patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations Year: 2020 Implications of new lung adenocarcinoma classification for oncologists Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 End-of-life antimicrobial usage in lung cancer: current perpectives and clinical practice Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 The effects of chest physiotherapy applications in patients diagnosed with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 653s Year: 2007 A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017